ORBENIN-DC INTRAMAMMARY INFUSION

  • Overview

Therapeutic Class

Orbenin®-DC Intramammary Infusion


Pharmaceutical Name
benzathine cloxacillin 


 
Features and Benefits
... long-lasting care for dry cow mastitis.

A stable, non-irritating suspension of benzathine cloxacillin containing the equivalent of 500 mg of cloxacillin per disposable syringe.

  • Longer duration of activity for more control of new infections late in the dry period.*

  • Broad spectrum of activity: Streptococcus agalactiae, S. aureus and B- lactamase Staph.

  • Features benefits of short-tip tubes.

  • No milk discard following a 28-day dry period, so cows aren’t delayed in getting back into the milking string.
    * Data on file at Schering-Plough Animal Health Corp.

Indications
Orbenin-DC is indicated in the treatment and prophylaxis of bovine mastitis in nonlactating cows due to Staphylococcus aureus and Streptococcus agalactiae.

WARNINGS
For use in dry cows only. Do not use within 4 weeks (28 days) of calving. Treated animals must not be slaughtered for food purposes within 4 weeks (28 days) of treatment. 
 
Dosage
For further information including dose rate and complete directions and warnings, please see the Product Label by clicking here.
 
Orbenin®-DC Intramammary Infusion is a registered trademark of Schering-Plough Animal Health Corporation.